What are the key laboratory methods for diagnosing STEC/EHEC infection and how is serotype O157:H7 typically distinguished?

What are the key laboratory methods for diagnosing STEC/EHEC infection and how is serotype O157:H7 typically distinguished?

• A. Detection of Shiga toxin or stx genes; culture on SMAC agar where O157:H7 does not ferment sorbitol; serotyping for O157 and H7
• B. PCR for invA gene; culture on Campy medium
• C. Serology for Shiga toxin antibodies; culture on blood agar
• D. Detection of lactose fermentation on MacConkey; identification by colony color

Answer: (C)

The key idea is that diagnosing STEC/EHEC rests on showing Shiga toxin production or the presence of stx genes and on isolating the organism with characteristics that point to the classic O157:H7 strain, then confirming its serotype. In practice, this means two parallel approaches: detect the toxin or its genes in the stool and culture the organism on a selective medium that highlights the typical O157:H7 profile. Detecting Shiga toxin directly from stool or by PCR for stx genes confirms that the bacterium has the virulence factor responsible for disease. This molecular or immunologic evidence is central to diagnosing STEC infections because the toxin is the principal pathogenic determinant. At the same time, culture on sorbitol-MacConkey agar helps differentiate O157:H7: this serotype historically shows little or no sorbitol fermentation, producing colorless colonies after overnight incubation, whereas most other E. coli ferment sorbitol and appear differently. Once a nonfermenting colony is suspected, serotyping for the O157 antigen and the H7 flagellar antigen is used to confirm the classic O157:H7 strain. It’s important to recognize that non-O157 STEC strains exist and may not be sorbitol nonfermenters, so broader testing for stx genes and additional typing are sometimes needed. Serology for Shiga toxin antibodies is not routinely used to diagnose acute infection, and routine culture on ordinary blood agar does not provide the specificity needed for STEC identification.

The key idea is that diagnosing STEC/EHEC rests on showing Shiga toxin production or the presence of stx genes and on isolating the organism with characteristics that point to the classic O157:H7 strain, then confirming its serotype. In practice, this means two parallel approaches: detect the toxin or its genes in the stool and culture the organism on a selective medium that highlights the typical O157:H7 profile.

Detecting Shiga toxin directly from stool or by PCR for stx genes confirms that the bacterium has the virulence factor responsible for disease. This molecular or immunologic evidence is central to diagnosing STEC infections because the toxin is the principal pathogenic determinant. At the same time, culture on sorbitol-MacConkey agar helps differentiate O157:H7: this serotype historically shows little or no sorbitol fermentation, producing colorless colonies after overnight incubation, whereas most other E. coli ferment sorbitol and appear differently. Once a nonfermenting colony is suspected, serotyping for the O157 antigen and the H7 flagellar antigen is used to confirm the classic O157:H7 strain.

It’s important to recognize that non-O157 STEC strains exist and may not be sorbitol nonfermenters, so broader testing for stx genes and additional typing are sometimes needed. Serology for Shiga toxin antibodies is not routinely used to diagnose acute infection, and routine culture on ordinary blood agar does not provide the specificity needed for STEC identification.